Hydrogel-based Drug Delivery System Industry Overview
The global hydrogel-based drug delivery system market size is anticipated to reach USD 10.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.5% from 2021 to 2028. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.
Hydrogel-based Drug Delivery System Market Segmentation
Grand View Research has segmented the global hydrogel-based drug delivery system market on the basis of polymer origin, delivery route, and region:
Based on the Polymer Origin Insights, the market is segmented into Natural, Synthetic, Hybrid.
- The natural segment dominated the market for hydrogel-based drug delivery systems and accounted for the largest revenue share of 32.3% in 2020.
- Proteins such as gelatin, lysosome, and collagen; and polysaccharides such as chitosan, hyaluronic acid, and alginate are used in the manufacturing of natural hydrogels. They have good cell adhesion properties but due to their mechanical and stability issues recently are less preferred in formulating drug delivery systems.
- Hydrogel-based drug delivery systems are made of synthetic polymer and are gaining more acceptance than naturally derived polymer owing to their higher drug absorbing capacity, improved mechanical properties, enhanced lifetime, and controllable degradation features.
- Natural and synthetic hydrogels are combined to prepare hybrid hydrogels. The phenomenon of hybrid polymerization is used in the manufacturing of an advanced version called SMART hydrogel. SMART hydrogels are stimuli-responsive and are different from conventional hydrogels as the drug release is dependent on physical or chemical stimuli.
Based on the Delivery Route Insights, the market is segmented into Subcutaneous, Ocular, Oral Cavity, Topical, Other.
- The ocular segment dominated the market for hydrogel-based drug delivery systems and accounted for the largest revenue share of 38.5% in 2020. Hydrogels are commonly used in ocular drug delivery applications because most of the hard and contact lenses are made of hydrogel films.
- The subcutaneous drug delivery segment is expected to witness a CAGR of 9.3% in the market for hydrogel-based drug delivery systems over the forecast period. Hydrogel being biodegradable material they are extensively used in the formulation of subcutaneous drug delivery systems.
- The implants degrade naturally inside the body thereby the need for its surgical removal is eliminated. Many subcutaneous hydrogel implants are recently developed to achieve controlled release of anticancer drugs.
- Drugs are incorporated into a hydrogel for local treatment of diseases in the buccal cavity such as fungal infection, periodontal disease, oral cancer, and stomatitis. The good adhesion and retention property of hydrogel with oral cavity mucosa help achieve local delivery of the drug.
Hydrogel-based Drug Delivery System Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa (MEA)
Key Companies Profile Market Share Insights
The key companies are observed to indulge in activities such as market expansion to generate more profit and sales. For instance, in January 2020, Ferring B.V. received approval to commercialize their hydrogel-based drug delivery device indicated for cervical ripening from the Minister of Health, Labor and Welfare (MHLW) Japan.
Some prominent players in the global hydrogel-based drug delivery system market include
- GALDERMA
- Blairex Laboratories, Inc.
- Johnson Johnson
- Bausch and Lomb
- Medtronic
- Ocular Therapeutix, Inc.
- Ferring B.V.
- Endo International plc
- Akorn, Incorporated
- Tolmar Pharmaceuticals, Inc.
Order a free sample PDF of the Hydrogel-based Drug Delivery System Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
